✦ LIBER ✦

The efficacy of erythropoietin in human immunodeficiency virus—infected end-stage renal disease patients treated by maintenance hemodialysis

✍ Scribed by Shrivastava, D.; Rao, T.K.S.; Sinert, R.; Khurana, E.; Lundin, A.P.; Friedman, E.A.

Book ID: 122948246
Publisher: Elsevier Science
Year: 1995
Tongue: English
Weight: 605 KB
Volume: 25
Category: Article
ISSN: 0272-6386
DOI: 10.1016/0272-6386(95)90573-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O018 Intradialytic hypertension in end-s

O018 Intradialytic hypertension in end-stage renal disease patients treated by maintenance hemodialysis – a dynamic analysis

✍ Tase, Adrian G.; Neacsu, Claudiu; Georgescu, Valentina; Ciocanea, Iuliana; Seica 📂 Article 📅 2014 🏛 Elsevier 🌐 English ⚖ 266 KB

The Hematopoietic Effect of Epotin (Reco

The Hematopoietic Effect of Epotin (Recombinant Human Erythropoietin-α) on Maintenance Hemodialysis End-Stage Kidney Disease Patients

✍ S. Al-Shohaib; D.S. Shaker; B.B. Ghaedi; M. Alyarim; S. Emara; M. Behairy 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 406 KB

Uremia therapy in patients with end-stag

Uremia therapy in patients with end-stage renal disease and human immunodeficiency virus infection: has the outcome changed in the 1990s?

✍ Ifudu Onyekachi; Joan D. Mayers; Jocelyn J. Matthew; Leila J. Macey; William Bre 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 354 KB

The Effect of Treatment With Recombinant

The Effect of Treatment With Recombinant Human Erythropoietin on Skeletal Muscle Function in Patients With End-Stage Renal Failure Treated With Regular Hospital Hemodialysis

✍ Davenport, A. 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 531 KB

Impaired Maraviroc and Raltegravir Clear

Impaired Maraviroc and Raltegravir Clearance in a Human Immunodeficiency Virus–Infected Patient with End-Stage Liver Disease and Renal Impairment: A Management Dilemma

✍ Alice K. Pau; Scott R. Penzak; Sarita D. Boyd; Mary McLaughlin; Caryn G. Morse 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB

The model for end-stage liver disease sc

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end-stage liver disease: A prospective cohort study

✍ Javier Murillas; Antonio Rimola; Montserrat Laguno; Elisa de Lazzari; Javier Ras 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB 👁 1 views

End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par